ZNF367 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.496000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.705600E-01
Normal-vs-Stage2
7.176800E-01
Normal-vs-Stage3
1.841580E-01
Normal-vs-Stage4
8.192200E-01
Stage1-vs-Stage2
8.175000E-01
Stage1-vs-Stage3
2.249800E-01
Stage1-vs-Stage4
9.459000E-01
Stage2-vs-Stage3
1.039810E-01
Stage2-vs-Stage4
9.207800E-01
Stage3-vs-Stage4
1.887190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.366000E-01
Normal-vs-AfricanAmerican
9.163400E-01
Normal-vs-Asian
7.795400E-01
Caucasian-vs-AfricanAmerican
7.284800E-01
Caucasian-vs-Asian
8.959600E-01
AfricanAmerican-vs-Asian
8.041400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.984200E-01
Normal-vs-Female
6.931600E-01
Male-vs-Female
5.206800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.269600E-01
Normal-vs-Age(41-60Yrs)
5.663400E-01
Normal-vs-Age(61-80Yrs)
8.936400E-01
Normal-vs-Age(81-100Yrs)
5.325600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.037800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.773400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.860810E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.835600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.210400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.816820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.826400E-01
Normal-vs-Daily Drinker
9.343800E-01
Normal-vs-Weekly Drinker
7.253800E-01
Normal-vs-Occasional Drinker
8.089800E-01
Normal-vs-Social Drinker
6.909400E-01
Non Drinker-vs-Daily Drinker
8.503000E-01
Non Drinker-vs-Weekly Drinker
7.315200E-01
Non Drinker-vs-Occasional Drinker
8.928000E-01
Non Drinker-vs-Social Drinker
8.318400E-01
Daily Drinker-vs-Weekly Drinker
5.816800E-01
Daily Drinker-vs-Occasional Drinker
7.375800E-01
Daily Drinker-vs-Social Drinker
6.745000E-01
Weekly Drinker-vs-Occasional Drinker
8.229200E-01
Weekly Drinker-vs-Social Drinker
8.292400E-01
Occasional Drinker-vs-Social Drinker
9.660600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.467200E-01
Normal-vs-Grade 2
8.228600E-01
Normal-vs-Grade 3
8.542400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.420450E-01
Grade 1-vs-Grade 3
8.229500E-02
Grade 1-vs-Grade 4
7.467200E-01
Grade 2-vs-Grade 3
5.374000E-01
Grade 2-vs-Grade 4
8.228600E-01
Grade 3-vs-Grade 4
8.542400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.123200E-01
Normal-vs-NonDiabetic
7.225000E-01
Diabetic-vs-NonDiabetic
1.456040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.179200E-01
Normal-vs-NoPancreatitis
7.718000E-01
Pancreatitis-vs-NoPancreatitis
9.975700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.371000E-01
Normal-vs-N1
7.236800E-01
N0-vs-N1
8.627400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.047000E-01
Normal-vs-TP53-NonMutant
5.710000E-01
TP53-Mutant-vs-TP53-NonMutant
2.523600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
